QNRX (Quoin Pharmaceuticals) ROE % Adjusted to Book Value: -123.40% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

QNRX Quoin Pharmaceuticals Ltd QNRX
26 GF Score
Price $4.15
! 1 Warning Sign
View Full Analysis

What is Quoin Pharmaceuticals ROE % Adjusted to Book Value?

Quoin Pharmaceuticals QNRX -1.19% 26 ROE % Adjusted to Book Value is -123.40% as of Mar. 2026. GuruFocus rates QNRX with a GF Score™ of 26/100. The stock has 1 warning sign investors should review.

Quoin Pharmaceuticals's ROE % for the quarter that ended in Mar. 2026 was -182.63%. Quoin Pharmaceuticals's PB Ratio for the quarter that ended in Mar. 2026 was 1.48. Quoin Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -123.40%.

Quoin Pharmaceuticals ROE % Adjusted to Book Value Related Terms

Quoin Pharmaceuticals ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Quoin Pharmaceuticals's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quoin Pharmaceuticals ROE % Adjusted to Book Value Chart

Quoin Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 0.00 -239.86 -156.38 -191.35 -85.81

Quoin Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -258.40 -163.76 0.00 -177.08 -123.40

QNRX vs RVPH, AIM, BRTX: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Quoin Pharmaceuticals's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quoin Pharmaceuticals ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quoin Pharmaceuticals's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Quoin Pharmaceuticals's ROE % Adjusted to Book Value falls into.


QNRX
26GF Score
Quoin Pharmaceuticals Ltd QNRX
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quoin Pharmaceuticals ROE % Adjusted to Book Value Calculation

Quoin Pharmaceuticals's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-141.59% / 1.65
=-85.81%

Quoin Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-182.63% / 1.48
=-123.40%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -123.40% mean?
Quoin Pharmaceuticals (QNRX) has a ROE % Adjusted to Book Value of -123.40% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Quoin Pharmaceuticals and its competitors.
Is Quoin Pharmaceuticals' ROE % Adjusted to Book Value too high?
Quoin Pharmaceuticals' current ROE % Adjusted to Book Value is -123.40%. Overall, Quoin Pharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Quoin Pharmaceuticals' ROE % Adjusted to Book Value compare to RVPH and AIM?
Quoin Pharmaceuticals' ROE % Adjusted to Book Value of -123.40% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Quoin Pharmaceuticals and its competitors. Quoin Pharmaceuticals's current ROE % Adjusted to Book Value is -123.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quoin Pharmaceuticals stock overvalued right now?
Quoin Pharmaceuticals (QNRX) has a current ROE % Adjusted to Book Value of -123.40%. The current ROE % Adjusted to Book Value is -123.40%. Quoin Pharmaceuticals' overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Quoin Pharmaceuticals (QNRX), the current ROE % Adjusted to Book Value is -123.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quoin Pharmaceuticals Business Description

Address 42127 Pleasant Forest Court, Ashburn, VA, USA, 20148-7349
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
26GF Score

Get the complete analysis for QNRX

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.15
Price